Celularity (CELU) Current Taxes (2019 - 2020)
Celularity's (CELU) quarterly Current Taxes came in at $81701.0 in Q3 2020, down 21.66% quarter-over-quarter from $104284.0 in Q2 2020.
Powered by 
Analysis
Celularity (CELU) Current Taxes (2019 - 2020) Analysis & Trends
Celularity (CELU) has reported Current Taxes for 2 consecutive years, with $81701.0 the latest figure, recorded in Q3 2020.
- On a quarterly basis, Current Taxes changed N/A year-over-year to $81701.0 in Q3 2020; TTM through Sep 2020 was $81701.0, a N/A change from a year earlier, with the FY2019 full-year figure at $18883.0, changed N/A from the prior year.
- Current Taxes was $81701.0 for Q3 2020 at Celularity, down from $104284.0 in the prior quarter.
- Over five years, Current Taxes peaked at $116891.0 in Q2 2019 and troughed at $18883.0 in Q4 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | 494,000.00 |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | 33.70 Mn |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | 9.31 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | - |
| 10 | Celularity | 36.35 Mn | 30.17 Mn | -3.27 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | 81,701.00 |
| Jun 30, 2020 | 104,284.00 |
| Mar 31, 2020 | 62,092.00 |
| Dec 31, 2019 | 18,883.00 |
| Jun 30, 2019 | 116,891.00 |